Menu

AbCellera Biologics Inc. (ABCL) Presents at UBS Global Biopharma Conference 2026 Transcript
📰

AbCellera Biologics Inc. (ABCL) Presents at UBS Global Biopharma Conference 2026 Transcript

All Articles on Seeking Alpha·about 19 hours ago
#Ye09wDSo
#seekingalpha#alice#abcellera#company#carl
Reading 0:00
15s threshold

AbCellera Biologics Inc. ( ABCL ) UBS Global Biopharma Conference 2026 November 17, 2026 10:20 AM EST

Company Participants

Carl L. Hansen - CEO, President & Chairperson

Conference Call Participants

Alice Nettleton - UBS Investment Bank, Research Division

Presentation

Alice Nettleton

UBS Investment Bank, Research Division

The next session at the UBS Biopharma Conference in London. I'm Alice Nettleton, one of the U.S. SMID biotech analysts at UBS. Happy to introduce AbCellera. We have with us Carl Hansen, CEO. Thank you so much for joining us.

Carl L. Hansen

CEO, President & Chairperson

Thanks, Alice. It's a pleasure to be here.

Alice Nettleton

UBS Investment Bank, Research Division

So just to start then, maybe we can start off with a brief overview of AbCellera for those who might be newer to the story, and you can cover the exciting data that you had earlier this year, and then we can move to some Q&A.

Carl L. Hansen

CEO, President & Chairperson

Okay. Great.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.